Ipilimumab (anti-CTLA-4) is an immunomodulatory моноклональный антитело directed against the клетка surface antigen CTLA-4 and also a type of immune checkpoint ингибитор.
Ipilimumab (anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.